Literature DB >> 23303013

VEGF and CD31 expression in arthritic synovium and cartilage of human knee joints.

R Melinte1, I Jung, Lia Georgescu, Simona Gurzu.   

Abstract

PURPOSE: To determine the histological differences and the particular aspects of local angiogenesis in knee joint of the patients with osteoarthritis (OA) and rheumatoid arthritis (RA).
MATERIALS AND METHODS: In 10 cases with RA and five OA, immunohistochemical stains were performed with CD31 and VEGF-A (Vascular Endothelial Growth Factor). All surgical samples provided from total knee joint arthroplasty. Angiogenesis was quantified in both synovial membrane and cartilage.
RESULTS: In patients with OA, villous proliferation of the synovial membrane was more prominent that in RA. In the last, invasion of the cartilage by the proliferated synovial tissue was more characteristic. The neovascularization was more intense in RA than in OA, in both synovium and degenerated cartilage. In RA, the vessels were immature in the superficial areas and became larger in the deep synovium. The local angiogenesis was characterized by sprouting and splitting (intussusceptions) mechanisms. In OA, the mature vessels predominated in the subintimal zones. Sprouting or non-sprouting mechanisms of local angiogenesis, which can indicate vascular formation from the resident mature vessels, were not identified in OA.
CONCLUSIONS: Angiogenesis seems to have particular behavior in RA and OA. In RA, local active angiogenesis seems to predominate but in OA up taking of the circulating precursors may be more intensely involved. Intra-articular inhibition of local angiogenesis could have therapeutically impact in RA but not in OA. Finally, we can conclude that there probably are many different pathways leading to the same joint damage having certain therapeutic consequences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23303013

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  7 in total

1.  Different synovial vasculogenic profiles of primary, rapidly destructive and osteonecrosis-induced hip osteoarthritis. An immunohistochemistry study.

Authors:  Simona Gurzu; Sabin Gligore Turdean; Sorin Tudor Pop; Ancuta Zazgyva; Ciprian Oliviu Roman; Mihaela Opris; Ioan Jung
Journal:  Int Orthop       Date:  2016-10-04       Impact factor: 3.075

Review 2.  The essential anti-angiogenic strategies in cartilage engineering and osteoarthritic cartilage repair.

Authors:  Song Chen; Yixuan Amy Pei; Ming Pei
Journal:  Cell Mol Life Sci       Date:  2022-01-14       Impact factor: 9.261

3.  Exploring the role of monocyte chemoattractant protein-1 in fibroblast-like synovial cells in rheumatoid arthritis.

Authors:  Xiang Tong; Dongdong Yu; Li Yu; Weiqian Chen; Yanling Wen; Pengcheng Gu
Journal:  PeerJ       Date:  2021-08-11       Impact factor: 2.984

4.  Angiogenic cytokine expression profiles in plasma and synovial fluid of primary knee osteoarthritis.

Authors:  Thomas Mabey; Sittisak Honsawek; Natthaphon Saetan; Yong Poovorawan; Aree Tanavalee; Pongsak Yuktanandana
Journal:  Int Orthop       Date:  2014-06-26       Impact factor: 3.075

5.  Differential protein expression in human knee articular cartilage and medial meniscus using two different proteomic methods: a pilot analysis.

Authors:  Elin Folkesson; Aleksandra Turkiewicz; Martin Englund; Patrik Önnerfjord
Journal:  BMC Musculoskelet Disord       Date:  2018-11-29       Impact factor: 2.362

6.  Hypoxic preconditioning stimulates angiogenesis in ischemic penumbra after acute cerebral infarction.

Authors:  Sijie Li; Yanbo Zhang; Guo Shao; Mingfeng Yang; Jingzhong Niu; Guowei Lv; Xunming Ji
Journal:  Neural Regen Res       Date:  2013-11-05       Impact factor: 5.135

7.  Effect of zoledronate on the expression of vascular endothelial growth factor-a by articular chondrocytes and synovial cells: an in vitro study.

Authors:  Jin Woong Yi; Woo-Suk Lee; Sang-Bum Kim; Youn-Moo Heo; Dong-Sik Chae
Journal:  J Bone Metab       Date:  2014-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.